Trial intelligence / Profile preview

Early botulinum toxin A plus physiotherapy for post-stroke arm flexor spasticity

ISRCTN57435427Phase 2Completed

Sponsor
Keele University
Start
Oct 2011
Modality
Recombinant Proteins and Enzymes
01

Overview

Phase 2, randomised, double-blind trial in upper extremity spasticity and stroke comparing Botox plus physiotherapy with Placebo saline plus physiotherapy (2 arms). Primary endpoint: Action Research Arm Test at 6 months. Started Oct 2011; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

upper extremity spasticitystroke

Beyond the preview

Go deeper on ISRCTN57435427.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN57435427.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call